Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India · Delayed Price · Currency is INR 89.30
0.00 (0.00%)
At close: Oct 16, 2026
NSE:ARISTO Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 61.13 | 42.97 | 54.13 | 38.03 | 26 |
Cash & Short-Term Investments | 61.13 | 42.97 | 54.13 | 38.03 | 26 |
Cash Growth | 42.25% | -20.61% | 42.32% | 46.25% | 2215.58% |
Accounts Receivable | 547.27 | 561.84 | 574.73 | 445.73 | 332 |
Other Receivables | - | 1.6 | - | 19.37 | - |
Receivables | 547.27 | 563.45 | 574.73 | 465.11 | 332 |
Inventory | 632.1 | 473.66 | 401.87 | 307.77 | 243.62 |
Other Current Assets | 61.07 | 77.53 | 19.53 | 15.53 | 23.79 |
Total Current Assets | 1,302 | 1,158 | 1,050 | 826.44 | 625.42 |
Property, Plant & Equipment | 236.37 | 239.52 | 216.79 | 167.15 | 144.58 |
Long-Term Investments | 1.83 | - | - | - | - |
Other Intangible Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Long-Term Deferred Tax Assets | - | - | - | 0.08 | - |
Other Long-Term Assets | 11.8 | 9.1 | 5.81 | 4.6 | -0 |
Total Assets | 1,552 | 1,406 | 1,273 | 998.29 | 770.02 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 696.91 | 770 | 688.64 | 446.04 | 352.13 |
Accrued Expenses | 16.88 | 18.28 | 10.15 | 11.6 | 5.19 |
Short-Term Debt | 247.21 | 106.65 | 78.51 | 99.44 | 126.68 |
Current Portion of Long-Term Debt | 30.46 | 35.49 | 30.28 | 23.8 | 17.26 |
Current Income Taxes Payable | 25.84 | 14.41 | 13.87 | 12.62 | 4.74 |
Other Current Liabilities | 17.41 | 10.92 | 14.23 | 1.35 | 3.41 |
Total Current Liabilities | 1,035 | 955.76 | 835.68 | 594.86 | 509.39 |
Long-Term Debt | 76.31 | 76.4 | 99.96 | 101.66 | 110.91 |
Long-Term Deferred Tax Liabilities | 0.08 | 0.77 | 1.14 | - | 0.86 |
Other Long-Term Liabilities | - | -0 | 0 | 0.22 | 0.2 |
Total Liabilities | 1,111 | 1,033 | 936.78 | 696.74 | 621.36 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 68.08 | 68.08 | 68.08 | 68.08 | 49.95 |
Retained Earnings | - | - | - | - | 98.71 |
Comprehensive Income & Other | 372.98 | 305.24 | 268.01 | 233.48 | - |
Shareholders' Equity | 441.06 | 373.31 | 336.09 | 301.55 | 148.66 |
Total Liabilities & Equity | 1,552 | 1,406 | 1,273 | 998.29 | 770.02 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 353.99 | 218.54 | 208.76 | 224.9 | 254.84 |
Net Cash (Debt) | -292.86 | -175.57 | -154.63 | -186.87 | -228.84 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -43.02 | -25.79 | -22.71 | -35.25 | -45.81 |
Filing Date Shares Outstanding | 6.81 | 6.81 | 6.81 | 6.81 | 5 |
Total Common Shares Outstanding | 6.81 | 6.81 | 6.81 | 6.81 | 5 |
Working Capital | 266.86 | 201.85 | 214.57 | 231.59 | 116.02 |
Book Value Per Share | 64.79 | 54.84 | 49.37 | 44.30 | 29.76 |
Tangible Book Value | 441.05 | 373.31 | 336.08 | 301.54 | 148.64 |
Tangible Book Value Per Share | 64.79 | 54.83 | 49.37 | 44.29 | 29.76 |
Land | 56.24 | 56.24 | 56.24 | 56.24 | 56.24 |
Buildings | 123.26 | 120.87 | 110.72 | 62.78 | 61.01 |
Machinery | 194.18 | 170.47 | 134.94 | 108.3 | 82.13 |
Construction In Progress | - | - | - | 10.97 | 0.98 |